Sanford Health

Chrystal Moldenhauer, living with cystic fibrosis, has seen significant improvements in her quality of life due to advances in medicine and supportive care at Sanford Health. Her daily treatments have reduced from up to eight hours to just half an hour, allowing her to engage fully in family life and work. Chrystal's participation in drug trials, particularly for Kalydeco, has been crucial in her improved health. Her care team at Sanford Health respects her knowledge of her body, fostering a collaborative approach to her treatment. Chrystal's life expectancy has increased due to better lung function and new medications, defying earlier statistics. The Moldenhauer family's move to Sioux Falls for better medical access has proven beneficial, enabling Chrystal to live a more active and fulfilling life.

FDA approves Cobenfy, a new schizophrenia treatment not acting on dopamine, with fewer side effects and potential to help negative symptoms. Available mid-October.

Jeff Koehn discovered a neck bump, sought medical help, and was diagnosed with tonsil cancer. He underwent surgery and participated in the EVOLVE clinical trial, which reduced treatment time and side effects. Koehn is now cancer-free and credits his care team for their attentive support.

Dandelion Health, founded by Mullainathan, Obermeyer, Gandhi, and Green, aims to improve healthcare through AI by collecting high-quality clinical data. They developed the Clinical AI Marketplace, which evaluates real-world data to validate AI algorithms, potentially speeding up drug approvals and improving clinical decisions. Their approach, using multimodal data and machine learning, could revolutionize healthcare by providing more accurate predictions and insights.